Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

100

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

100 results for “Yellow fever”

Learn how ShareScore rates datasets ↗
ClinicalTrials.gov36/100

Study of Live Attenuated Japanese Encephalitis Vaccine (ChimeriVax™-JE) and Yellow Fever Vaccine (STAMARIL®)

ClinicalTrials.gov study NCT00982137. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Administered With a Yellow Fever Vaccine in Adults

ClinicalTrials.gov study NCT03342898. IPD Sharing: YES. Countries: 1. Publications: 2.

controlledIPD-YESFeb 2026View details →
dryad36/100

Data from: The effect of parasite infection on the recombination rate of the yellow fever mosquito Aedes aegyti

Open the record for dataset details and reuse information.

publicDec 2019View details →
dryad32/100

Data from: Screening test for neutralizing antibodies against yellow fever virus, based on a flavivirus pseudotype

Given the possibility of yellow fever virus reintroduction in epidemiologically receptive geographic areas, the risk of vaccine supply disruption is a serious issue. New strategies to reduce the doses of injected vaccines should be evaluated very carefully in terms of immunogenicity. The plaque reduction test for the determination of neutralizing antibodies (PRNT) is particularly time-consuming and requires the use of a confinement laboratory. We have developed a new test based on the use of a non-infectious pseudovirus (WN/YF17D). The presence of a reporter gene allows sensitive determination of neutralizing antibodies by flow cytometry. This WN/YF17D test was as sensitive as PRNT for the follow-up of yellow fever vaccinees. Both tests lacked specificity with sera from patients hospitalized for acute Dengue virus infection. Conversely, both assays were strictly negative in adults never exposed to flavivirus infection or vaccination, and in patients sampled some time after acute Dengue infection. This WN/YF17D test will be particularly useful for large epidemiological studies and for screening for neutralizing antibodies against yellow fever virus.

opencc-zeroDec 2016View details →
ClinicalTrials.gov32/100

Non-interference Study of MR and Yellow Fever Vaccines Among Bangladeshi Infants Aged 9-12 Months

ClinicalTrials.gov study NCT06815835. IPD Sharing: NO. Countries: 1. Publications: 14.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Yellow Fever Vaccine in Patients With Rheumatic Diseases

ClinicalTrials.gov study NCT03430388. IPD Sharing: UNDECIDED. Countries: 1. Publications: 38.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Safety and Tolerability of an Antibody Against Yellow Fever Virus (TY014) in Humans

ClinicalTrials.gov study NCT03776786. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Complementary Study of the Duration of Post-vaccination Against Yellow Fever Immunity in Children

ClinicalTrials.gov study NCT02990182. IPD Sharing: Not stated. Countries: 1. Publications: 9.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Clinical Study of Immunity Duration of Yellow Fever Vaccine in Military

ClinicalTrials.gov study NCT03338231. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Study on an Investigational Yellow Fever Vaccine Compared With Stamaril in Adults in Europe and Asia

ClinicalTrials.gov study NCT05011123. IPD Sharing: YES. Countries: 6. Publications: 0.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov32/100

Immunogenicity and Safety of Fractional Doses of Yellow Fever Vaccines (YEFE)

ClinicalTrials.gov study NCT02991495. IPD Sharing: UNDECIDED. Countries: 2. Publications: 4.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Training Study to Characterize Biomarkers to Chickenpox and Yellow Fever Vaccines

ClinicalTrials.gov study NCT01765413. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Immunogenicity and Safety of the Yellow Fever Vaccine in HIV Infected Individuals

ClinicalTrials.gov study NCT03132311. IPD Sharing: NO. Countries: 1. Publications: 2.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Yellow Fever Immune Response at Single Cell Resolution

ClinicalTrials.gov study NCT03458780. IPD Sharing: Not stated. Countries: 1. Publications: 8.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Yellow Fever Virus Vaccine and Immune Globulin Study

ClinicalTrials.gov study NCT00254826. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Non- Inferiority Fractional-doses Trial for Yellow Fever Vaccine

ClinicalTrials.gov study NCT04059471. IPD Sharing: NO. Countries: 2. Publications: 3.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

The Yellow Fever Vaccine Immunity in HIV Infected Patients : Development of New Assays for Virological and Immunological Monitoring in HIV Infected Patient.

ClinicalTrials.gov study NCT01426243. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy Toddlers

ClinicalTrials.gov study NCT01436396. IPD Sharing: YES. Countries: 2. Publications: 0.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov32/100

Immunogenicity of Co-administered Yellow Fever and Measles, Mumps, and Rubella (MMR) Vaccines

ClinicalTrials.gov study NCT03368495. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Duration of Immunity 10 Years After a Dose-response Study With Yellow Fever Vaccine - Complementary Study

ClinicalTrials.gov study NCT04416477. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record